Trial Profile
Pragmatic RCT of High-dose Oral Montelukast for Moderate and Severe Pediatric Acute Asthma Exacerbations
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 17 Nov 2023
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 05 Nov 2022 Planned End Date changed from 5 Sep 2023 to 5 Sep 2029.
- 05 Nov 2022 Planned primary completion date changed from 31 Aug 2023 to 31 Aug 2028.
- 05 Nov 2022 Planned initiation date changed from 1 Sep 2022 to 1 Sep 2025.